Anti-inflammatory drugs did not speed COVID-19 recovery but prevented deaths, national study finds

Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone, according to a national study led by Washington University School of Medicine in St. Louis. The study was coordinated by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), also part of HHS.